the minimally invasive revolution in general surgery

Inventing
Percutaneous Surgery

The world's first minimally invasive, reversible ostomy device.
A 20-minute percutaneous intervention replacing open surgery.

The Challenge

250,000+ patients* per annum are indicated for Ostomy

IBDPseudo obstructionDiverticulitis

Not sick enough

Patients avoid surgery due to poor outcomes and quality of life

Bowel resectionDecomp. ostomy

Surgical Window

Up to $60,000 total cost
30% severe complication rate

Metastatic diseaseAnesthetic risk

Too sick

Up to 55,000 deaths per year

* US only

The Solution

Replacing
Surgery

The world's first minimally invasive ostomy. A percutaneous device that accesses the bowel through a single needle puncture and reverses when the crisis passes.

Patent-Pending
Percutaneous Stoma Kit
2-Step Deployment System

Truly Percutaneous

Local anesthesia needle access. No operating room. No general anesthesia. A procedure that takes 20 minutes.

Reversible Ostomy

Office-based stoma closure. The stent is removed when no longer indicated, restoring continuity without a second surgery.

Simplicity by Design

Two Steps.
Zero Compromise.

From needle puncture to active stoma in two steps and 20 minutes.

01

Single Puncture Fixation

The patent-pending Pexy device is deployed through a single needle puncture under local anesthesia, anchoring the stoma to the abdominal wall without sutures or open incision.

02

Stent Introduction

A decompressive stent is introduced through the fixation point, creating a controlled ostomy that relieves bowel obstruction in minutes — and is removable when the obstruction resolves.

20 min
Procedure Time
Local
Anesthesia
Office-based
Reversibility
Pending
Patent Status
Market Opportunity

$2.6B Serviceable Market

The US-only serviceable addressable market spans three distinct revenue streams across decompression, protection, and recurring disposables.

$1.0B
Decompressive Market

135,000 patients/year requiring decompression for bowel obstruction

$1.1B
Protective Market

145,000 patients/year requiring protective ostomy during surgical recovery

$500M
Disposables

Recurring revenue from per-procedure device kits and stent replacements

US Only
Addressable market scales significantly with EU and APAC expansion
The Team

Built by Pioneers

Ido Sadan

Ido Sadan

M.Sc
Chief Executive Officer

Expert in minimally invasive medical devices.

Eran Shlomovitz

Eran Shlomovitz

MD
Chief Medical Officer

Surgeon and radiologist with deep clinical expertise.

Eli Bekhor

Eli Bekhor

MD
Chief Scientific Officer

Physician with extensive startup experience.

KOL Advisors
LL

Lee L. Swanstrom

MD
KOL Advisor

Pioneer of minimally invasive surgery. Former SAGES President. 350+ publications.

PG

Peter G. Chait

MD
KOL Advisor

Pioneer of minimally invasive techniques. Inventor. 100+ publications.

Connect

Contact
the CEO

For investor conversations, press inquiries, or partnership discussions, reach out directly to our founding team.

IS
Contact
Ido Sadan, CEO
PhantomGI

Inventing percutaneous surgery. The world's first minimally invasive, reversible ostomy device.

Navigate
© 2026 PhantomGI. All rights reserved.